Status:
COMPLETED
Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Kidney Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the effect of empagliflozin on oxidative stress in patients with type 2 diabetes after kidney transplantation. The association is examined by comparing the ...
Detailed Description
With the purpose of studying the antioxidant activity of empagloflozin 25mg will add on insulin in 20 patients after kidney transplant and will compare with 20 diabetic recipient of kidney transplant ...
Eligibility Criteria
Inclusion
- Diagnosed with type 2 diabetes
- HbA1c: 6.5-9.0%
- post kidney transplant
- stable graft function
Exclusion
- pancreas and kidney transplant
- history of recurrent urinary tract infection
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04918407
Start Date
January 1 2022
End Date
August 5 2025
Last Update
September 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Labbafinezhd Hospital
Tehran, Iran, 166663423
2
SBMU
Tehran, Iran, 1666664321